Nu Skin Enterprises Inc (NUS)
Official siteCONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE
Market Cap: $196.17M
Last updated: Nov 17, 2026 at 11:06 AM ET
Nu Skin Enterprises Inc (NUS) Stock Forecast
Analysts expect Nu Skin Enterprises (NUS) to earn $0.60 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.28B. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is $1.13.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 88.3% and revenue estimates rise 9.4%.
- Fiscal year ending Dec 31, 2026
- $0.60
- EPS consensus, revenue $1.28B
- Fiscal year ending Dec 31, 2027
- $1.13
- EPS consensus, revenue $1.40B
- Next report
- Feb 10, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.60 | $0.60 to $0.60 | 1 | $1.28B | $1.28B to $1.28B | 1 |
| Dec 31, 2027 | $1.13 | $1.13 to $1.13 | 1 | $1.40B | $1.40B to $1.40B | 1 |
Quarterly Estimates
The EPS consensus falls from $0.27 for the quarter ending Dec 31, 2026 to $0.16 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.27 | $0.26 to $0.28 | 2 | $350.98M | $340.55M to $364.88M | 2 |
| Mar 31, 2027 | $0.16 | $0.16 to $0.16 | 1 | $328.70M | $328.70M to $328.70M | 1 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 0 upward and 3 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
| Quarter ending Mar 31, 2027 | 0 | 1 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 40.0% from $1.00.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.60 | $0.82 | $0.82 | $0.82 | $1.00 | -40.0% |
| Fiscal year ending Dec 31, 2027 | $1.13 | $1.16 | $1.16 | $1.16 | $1.32 | -14.4% |
| Quarter ending Mar 31, 2027 | $0.16 | $0.19 | $0.19 | $0.19 | $0.23 | -30.4% |
Frequently Asked Questions About NUS
What is the NUS stock forecast?
Consensus analyst estimates put Nu Skin Enterprises's EPS at $0.60 for the fiscal year ending Dec 31, 2026, on revenue of $1.28B.
What EPS do analysts expect from NUS next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.60, with estimates from $0.60 to $0.60 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $1.13, with estimates from $1.13 to $1.13 from 1 analyst.
What revenue do analysts expect from Nu Skin Enterprises next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.28B, with estimates from $1.28B to $1.28B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.40B, with estimates from $1.40B to $1.40B.
How many analysts cover NUS?
1 analyst estimates EPS for Nu Skin Enterprises for the fiscal year ending Dec 31, 2026.
NUS pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors